ASM Microbe 2026
June 4-7, 2026 – Washington, DC, USA
ADLM 2026
July 26-30, 2026 – Anaheim, CA, USA

ELISPOT Protocol for Detection of TNFα Secreted by Microglia

Introduction of ELISPOT to Study Microglia's TNFα

The ELISPOT assay was originally designed to study the secretion of antibodies from B cells and then was modified to study secretion of cytokines and chemokines from immune system cells. Due to its high sensitivity, ELISPOT remains the technique of choice to study the frequency of cytokine secreting immune system cells in cancer research, AIDS research, and immunization and vaccine studies.

ELISPOT assays are typically used to study cytokine secretion by cells from peripheral blood and lymphoid tissues. However, this technology can be used on other cell types, including microglial cells in the central and peripheral nervous systems. Microglial cells are the resident macrophages in brain and in spinal cord and provide immune defense of the CNS: they resemble immune system cells in that they also secrete cytokines and chemokines. For example, microglia may secrete pro-inflammatory cytokines, including IL-1β and TNFα, that can affect neuronal function, induce neurodegeneration, and are also implicated in pain.

In our current study, we adapted the ELISPOT assay to study the frequency of TNFα secreting microglial BV2 cells, which are similar to naturally occurring microglial cells. Our study has shown that, in addition to immunology studies, ELISPOT can also be used as a powerful tool for neuroscience research to study mechanisms underlying protein secretion from microglial cells. In addition, ELISPOT can be used for high-throughput screening of potent neuroprotective drugs.

Materials of ELISPOT to Study Microglia's TNFα

Culture of BV2 Cells

  1. Growth media: 1 L of DMEM with glucose (4.5 g/L) and L-glutamine (4 mM), 100 mL fetal calf serum, sodium bicarbonate (3.7 g/L), 1×Pen/Strep/Amphotericin (10 mL/L).
  2. PBS/EDTA containing 0.1 M NaCl, 0.01 M NaH2PO4 · monohydrate, and 0.04% EDTA-free acid (1.37 mM EDTA). Dissolve salts in water and adjust pH to 7.5. Store at room temperature.
  3. 1× phosphate-buffered saline (PBS).
  4. Centrifuge capable of spinning 50-mL culture tubes at 500 × g.
  5. Humidified incubator.
  6. Hemacytometer to count lymphocytes under the microscope.
  7. Trypan blue dye.
  8. Upright microscope equipped with bright-field illumination and phase contrast condenser.
  9. Culture flasks of various sizes.

ELISPOT Assay

  1. Commercially available ready-to-use ELISPOT assay kits to study secretion of mouse TNF-A (EL410). Each kit includes a 96-well PVDF membrane-backed plate precoated with capture antibody, a concentrated solution of detection antibody, a concentrated solution of streptavidin conjugated alkaline phosphatase, BCIP/NBT chromogenic substrate, wash and dilution buffers.
  2. Mitogens to stimulate release of cytokines from cultured BV2 cells: Lipopolysaccharides (LPS) from Escherichia coli.
  3. Hand-held Nunc-Immuno™ 12-plate washer.
  4. Membrane-removal device.
  5. ELISPOT plate reader QHub.

Methods of ELISPOT to Study Microglia's TNFα

Culture of BV2 Cells

Like many other types of cells, BV2 cells are stored frozen in liquid nitrogen (e.g., five million cells per vial) and before they can be plated into the ELISPOT plates they need to be thawed and transferred into fresh culture media. Procedures are performed at room temperature unless specified otherwise.

  1. Remove a vial with frozen BV2 cells from liquid nitrogen storage tank and thaw it rapidly at 37°C (1 min/1 mL of cell suspension).
  2. Add 1 mL of thawed cells to 15 mL growth media prewarmed at 37°C.
  3. Spin cells in a centrifuge at 500 × g for 5 min at room temperature.
  4. Remove supernatant and discard it. Add 10 mL of growth media.
  5. Spin cells again in a centrifuge for 5 min.
  6. Discard supernatant and resuspend cells in 15 mL of a fresh growth media in a culture flask.
  7. Culture cells until they are confluent (approximately 48 h).
  8. Prewarm fresh culture media at 37°C.
  9. Discard the media from the culture flask and wash adhered BV2 cells twice with 10 mL of PBS.
  10. Add PBS/EDTA to the flask and incubate at 37°C until cells begin to detach (10–15 min).
  11. Shake cells, add 15 mL of growth media, and transfer cells into a 50-mL conical tube.
  12. Centrifuge cells for 5 min at 500 × g.
  13. Discard supernatant and resuspend cells in 10 mL of prewarmed growth media.
  14. Mix cell sample (50 ML) 1:2 with trypan blue dye and pipette 10 ML of that mixture into each side of a hemacytometer under a coverslip. Count cells under the microscope using a 20× lens and phase contrast condenser (see Note 1).

ELISPOT Assay

  1. Plate BV2 cells (100 ML/well) into the ELISPOT plates at cell concentrations of 1.2 ×103 and 104 cells/mL (see Note 2).
  2. Stimulate BV2 cells with LPS at 1 Mg added directly to cells in ELISPOT plates and incubated in a CO2 incubator at 37°C for 18 h (see Notes 3–5).
  3. After finishing the incubation, remove growth media from the plates with a multichannel pipette and wash the plate once with 1× PBS and then add 100μL of PBS/EDTA to plate for 10 min to remove adherent cells. Wash the plate by rinsing wells four times with wash buffer (see Notes 6–8).
  4. Make working solutions of the detection antibodies by mixing concentrated detection antibodies 1:120 with dilution buffer.
  5. Add 100μL of detection antibody working solution into each well and incubate ELISPOT plates overnight in the refrigerator or in the cold room at 2–8°C (see Note 9).
  6. Wash plates three times with the wash buffer.
  7. Prepare a working solution of streptavidin-alkaline phosphatase by mixing the concentrated stock solution 1:120 with the corresponding dilution buffer.
  8. Add 100 μL of streptavidin-alkaline phosphatase working solution to each well and incubate for 2 h.
  9. Wash plates three times with wash buffer.
  10. Add 100 μL of ready-to-use BCIP/NBT substrate into each well and incubate for 30–60 min in a place protected from direct light.
  11. Wash plates three times with distilled water and let them dry completely.
  12. Quantify spots using an automated ELISPOT reader (see Note 10).

Typical ELISPOT image of TNFA secreted by microglial BV2 cells.Figure 1. Typical ELISPOT image of TNFA secreted by microglial BV2 cells.

Notes of ELISPOT to Study Microglia's TNFα

  1. Overfilling the hemacytometer with cell solution may result in inaccurate cell quantification. While counting cells on a hemacytometer, first find the middle square which contains 25 smaller squares and count cells in 5 of them. Calculate the average and multiply by 25 (total number of squares in that area) and then multiply by 2 (cell dilution factor), multiply by 10,000 to determine the number of cells in 1 mL of original cell suspension. The resulting number should be used for calculating serial dilutions of cells.
  2. Making serial dilutions of cells allows the user to avoid overdevelopment of the ELISPOT plate and to obtain a quantifiable number of spots that can be counted either manually or using an automated ELISPOT plate reader.
  3. For better well-to-well reproducibility, cells need to be mixed thoroughly before adding them into the wells. This may require shaking the tube containing the cells after filling every four wells in the ELISPOT plate.
  4. Plates can be wrapped in aluminum foil to provide even heat distribution across the bottom of the ELISPOT plates during their incubation. This helps to improve well-to-well spot consistency across the plate. Aluminum foil also helps to reduce background staining. This is a very simple procedure which can be done as follows: before plating the cells, the ELISPOT plate is placed onto 13 × 16-cm piece of aluminum foil; the cells are then added into the wells and the plate is covered with the lid. The edges of the foil are shaped loosely around the edges of the plate to wrap it. After finishing the incubation of the cells, the foil can be removed and either discarded or saved and used on the next ELISPOT plate.
  5. Shelves in the CO2 incubator must be leveled to avoid moving cells toward one side of the well: this may produce under- and overdeveloped parts of the well and hinder quantification of spots. It is also important to avoid disturbing cultured cells (e.g., by slamming the door of the incubator) during the incubation, which may cause the formation of weakly stained fuzzy spots.
  6. Make sure that the height of the prongs in the hand held plate washer is properly adjusted, so prongs do not touch the membranes on the bottom of ELISPOT plates. PVDF membranes backing the ELISPOT plate are fragile and can get easily punctured by protruding prongs.
  7. Between washes it is important to tap out the excess liquid in the wells onto a paper towel to prevent diluting the subsequent reagents added to the plate.
  8. Addition of EDTA to PBS is highly recommended because it facilitates the removal of microglial cells sticking to the membranes backing ELISPOT plates. Unremoved cells induce a strong background staining that obscures TNFA formed spots and affects their quantification.
  9. To ensure accurate results, reagent addition should be continuous and completed within 15 min.
  10. ELISPOT plates must be completely dry before analysis using an ELISPOT reader because wet membranes appear dark, obscuring the detection and quantification of spots.

Reference

  1. Alexander E. Kalyuzhny. Handbook of ELISPOT. Methods in Molecular Biology. 2012, 792. Electronic. ISSN: 978-1-61779-325-7.
Inquiry Basket